Loading...
Mediclin AG
MED.DE•XETRA
Healthcare
Medical - Care Facilities
€3.02
€-0.04(-1.31%)
Mediclin AG (MED.DE) Financial Performance & Statements
Review Mediclin AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-1.68%
↓ 1.68%
Operating Income Growth
320.43%
↑ 320.43%
Net Income Growth
330.50%
↑ 330.50%
Operating Cash Flow Growth
3.29%
↑ 3.29%
Operating Margin
7.14%
↑ 7.14%
Gross Margin
47.80%
↑ 47.80%
Net Profit Margin
3.32%
↑ 3.32%
ROE
11.99%
↑ 11.99%
ROIC
7.23%
↑ 7.23%
Mediclin AG (MED.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Mediclin AG stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $190.58M | $190.24M | $182.54M | $185.45M |
| Cost of Revenue | $29.27M | $30.33M | $161.72M | $169.58M |
| Gross Profit | $161.31M | $159.90M | $20.82M | $15.87M |
| Gross Profit Ratio | $0.85 | $0.84 | $0.11 | $0.09 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $18.10M |
| Operating Expenses | $142.29M | $137.38M | $144.05M | $11.78M |
| Total Costs & Expenses | $171.56M | $167.71M | $174.68M | $181.36M |
| Interest Income | $588582.00 | $677286.00 | $708793.00 | $648591.00 |
| Interest Expense | $5.90M | $6.03M | $6.10M | $5.95M |
| Depreciation & Amortization | $13.15M | $12.66M | $12.39M | $12.10M |
| EBITDA | $32.76M | $35.86M | $20.95M | $16.84M |
| EBITDA Ratio | $0.17 | $0.19 | $0.11 | $0.09 |
| Operating Income | $19.02M | $22.52M | $7.85M | $4.09M |
| Operating Income Ratio | $0.10 | $0.12 | $0.04 | $0.02 |
| Other Income/Expenses (Net) | -$5.31M | -$5.36M | -$5.39M | -$5.31M |
| Income Before Tax | $13.70M | $17.17M | $2.46M | -$1.21M |
| Income Before Tax Ratio | $0.07 | $0.09 | $0.01 | -$0.007 |
| Income Tax Expense | $3.74M | $2.78M | $460577.00 | $223407.00 |
| Net Income | $9.94M | $14.30M | $2.00M | -$1.40M |
| Net Income Ratio | $0.05 | $0.08 | $0.01 | -$0.008 |
| EPS | $0.21 | $0.29 | $0.04 | -$0.03 |
| Diluted EPS | $0.21 | $0.29 | $0.04 | -$0.03 |
| Weighted Avg Shares Outstanding | $47.50M | $49.94M | $49.94M | $47.50M |
| Weighted Avg Shares Outstanding (Diluted) | $47.50M | $49.94M | $49.94M | $47.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan